Gary D. Pilcher

949 total citations
16 papers, 211 citations indexed

About

Gary D. Pilcher is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Gary D. Pilcher has authored 16 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Physiology and 3 papers in Oncology. Recurrent topics in Gary D. Pilcher's work include Nitric Oxide and Endothelin Effects (3 papers), Lanthanide and Transition Metal Complexes (2 papers) and Glycosylation and Glycoproteins Research (2 papers). Gary D. Pilcher is often cited by papers focused on Nitric Oxide and Endothelin Effects (3 papers), Lanthanide and Transition Metal Complexes (2 papers) and Glycosylation and Glycoproteins Research (2 papers). Gary D. Pilcher collaborates with scholars based in United States, Germany and Sweden. Gary D. Pilcher's co-authors include Michael J. Graziano, Mike A. Breider, Thomas P. Sanderson, James F. Reindel, Mary E. Marmion, Steven R. Woulfe, Felix A. de la Iglesia, Walter F. Bobrowski, Dennis L. Nosco and Jay O. Knipe and has published in prestigious journals such as Biochemical Pharmacology, Journal of Pharmaceutical Sciences and Toxicology and Applied Pharmacology.

In The Last Decade

Gary D. Pilcher

16 papers receiving 198 citations

Peers

Countries citing papers authored by Gary D. Pilcher

Since Specialization

Citations

This map shows the geographic impact of Gary D. Pilcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary D. Pilcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary D. Pilcher more than expected).

Fields of papers citing papers by Gary D. Pilcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary D. Pilcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary D. Pilcher. The network helps show where Gary D. Pilcher may publish in the future.

Co-authorship network of co-authors of Gary D. Pilcher

This figure shows the co-authorship network connecting the top 25 collaborators of Gary D. Pilcher. A scholar is included among the top collaborators of Gary D. Pilcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary D. Pilcher. Gary D. Pilcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Investigations on the Relationship Between Ovarian, Endocrine, and Renal Findings in Nonclinical Safety Studies of the γ-Secretase Inhibitor Avagacestat 2019 ·Toxicological Sciences ·(unknown), Thomas P. Sanderson, Gary D. Pilcher, Michael J. Graziano	2
2	Nonclinical Safety Assessment of the γ-Secretase Inhibitor Avagacestat 2018 ·Toxicological Sciences ·(unknown), Thomas P. Sanderson, Gary D. Pilcher, Michael J. Graziano	10
3	Preclinical Pharmacokinetics and In Vitro Metabolism of BMS-605339: A Novel HCV NS3 Protease Inhibitor 2014 ·Journal of Pharmaceutical Sciences ·Susan Jenkins, Paul M. Scola, Fiona McPhee, Jay O. Knipe, Christoph Gesenberg, (unknown), Vinod Arora, Gary D. Pilcher, Kenneth S. Santone	6
4	Determination of Relative Notch1 and γ-Secretase-Related Gene Expression in Puromycin-Treated Microdissected Rat Kidneys 2013 ·Gene Expression ·Damir Simic, (unknown), (unknown), (unknown), (unknown), Roderick T. Bunch, Gary D. Pilcher, Thomas P. Sanderson, Terry Van Vleet	2
5	O4‐06‐08: Safety and tolerability of BMS‐708163 in a phase II study in mild‐to‐moderate Alzheimer's disease 2011 ·Alzheimer s & Dementia ·Stephen Salloway, Vlad Coric, Mark Brody, Niels Andreasen, Christopher van Dyck, Hilkka Soininen, Stephen Thein, (unknown), Sandeep Kumar, Gary D. Pilcher, Susan Colby, Linda Rollin, Howard Feldman, Robert Berman	4
6	Systemic Proliferative Changes and Clinical Signs in Cynomolgus Monkeys Administered a Recombinant Derivative of Human Epidermal Growth Factor 2001 ·Toxicologic Pathology ·James F. Reindel, (unknown), Gary D. Pilcher, Walter F. Bobrowski, (unknown), Felix A. de la Iglesia	9
7	Retinal Degeneration in Rats Induced by CI-1010, a 2-Nitroimidazole Radiosensitizer 1998 ·Toxicologic Pathology ·Mike A. Breider, Gary D. Pilcher, Michael J. Graziano, (unknown)	24
8	Synthesis and characterization of novel N3O3-Schiff base complexes of 99gTc, and in vivo imaging studies with analogous 99mTc complexes 1996 ·Nuclear Medicine and Biology ·Mary E. Marmion, Steven R. Woulfe, (unknown), Gary D. Pilcher, Dennis L. Nosco	11
9	Recombinant Human Epidermal Growth Factor1-48-Induced Structural Changes in the Digestive Tract of Cynomolgus Monkeys (Macaca fascicularis) 1996 ·Toxicologic Pathology ·James F. Reindel, Gary D. Pilcher, (unknown), Jeffrey R. Haskins, Felix A. de la Iglesia	3
10	Hepatic microsomal induction profile of carbamic acid [[2,6-bis(1-methylethyl)phenoxy] sulfonyl]-2,6-bis(1-methylethyl) phenyl ester, monosodium salt (PD138142-15), a novel lipid regulating agent 1995 ·Biochemical Pharmacology ·Donald G. Robertson, Brian R. Krause, Devin Welty, Grushenka H.I. Wolfgang, Michael J. Graziano, Gary D. Pilcher, (unknown)	5
11	The Synthesis and Screening of Nonionic Gadolinium (III) DTPA-Bisamide Complexes as Magnetic Resonance Imaging Contrast Agents 1991 ·Investigative Radiology ·(unknown), David White, (unknown), Dennis A. Moore, Rebecca Wallace, Weiwei Lin, Jeff F. Dunn, (unknown), William P. Cacheris, Gary D. Pilcher, Karen P. Galen, Michael R. Hynes, (unknown), Huawen Lin, Max Adams	17
12	Mechanism of the serum thyroid hormone lowering effect of perfluoro‐n‐decanoic acid (PFDA) in rats 1989 ·Journal of Toxicology and Environmental Health ·(unknown), Gary D. Pilcher, (unknown)	45
13	Effect of thyroxine supplementation on the response to perfluoro‐n‐decanoic acid (PFDA) in rats 1988 ·Journal of Toxicology and Environmental Health ·(unknown), Gary D. Pilcher, (unknown)	16
14	The effects of perfluoro-n-decanoic acid (PFDA) on rat heart ?-receptors, adenylate cyclase, and fatty acid composition1 1987 ·Toxicology and Applied Pharmacology* ·Gary D. Pilcher	7
15	The effects of perfluoro-n-decanoic acid in the rat heart 1986 ·Toxicology and Applied Pharmacology ·Gary D. Pilcher, (unknown)	10
16	Thyroid, bradycardic and hypothermic effects of perfluoro‐n‐decanoic acid in rats 1985 ·Journal of Toxicology and Environmental Health ·(unknown), Gary D. Pilcher	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seyed Mohamad Sadegh Modaresi Breakdown of academic impact, for papers by Diane Kampa Breakdown of academic impact, for papers by Marci G. Smeltz Breakdown of academic impact, for papers by Daisaku Miura Breakdown of academic impact, for papers by L. Gil Breakdown of academic impact, for papers by Soumya Poddar Breakdown of academic impact, for papers by Robert R. Roussel Breakdown of academic impact, for papers by Yi M. Weaver